Disc Medicine, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
IRON Nasdaq 2834 www.discmedicine.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Disc Medicine, Inc.

Is Disc Medicine (IRON) Offering An Opportunity After Recent Volatility And DCF Valuation Gap - Jan 13th, 2026 6:08 am
Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer - Jan 12th, 2026 2:30 pm
Disc Medicine Highlights Recent Achievements and Key Business Objectives and Milestones for 2026 - Jan 12th, 2026 6:30 am
What Investors Should Know About a $511K Disc Medicine Insider Sale and a 26% Stock Run - Jan 11th, 2026 2:12 pm
Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference - Jan 7th, 2026 6:30 am
Seadrill, Vestis, Mastercraft Boat, and More Stocks See Action From Activist Investors - Dec 26th, 2025 3:14 pm
Has Disc Medicine’s 2025 Surge Already Gone Too Far After Pipeline Progress Fuels Rally? - Dec 11th, 2025 8:11 pm
Leering Partners Lifts Disc Medicine, Inc. (IRON) Following EPP Drug NDA Application - Dec 11th, 2025 5:44 am
This is Why Disc Medicine, Inc. (IRON) is a Buy on Wall Street - Dec 8th, 2025 10:20 pm
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting - Dec 6th, 2025 6:00 am
Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock - Nov 19th, 2025 8:24 am
What Disc Medicine (IRON)'s Bitopertin Fast-Track Review and Rising R&D Spend Mean for Shareholders - Nov 8th, 2025 6:15 am
Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update - Nov 6th, 2025 6:30 am
Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting - Nov 3rd, 2025 7:00 am
Disc Medicine to Participate in Upcoming Investor Conferences - Oct 31st, 2025 6:30 am
Disc Medicine's Outlook Strengthens After Financing and Pipeline Update, Morgan Stanley Says - Oct 30th, 2025 10:36 am
Disc Medicine (IRON): Evaluating Valuation After New Clinical Trial Plans and FDA Recognition Boost Pipeline Momentum - Oct 29th, 2025 6:12 am
What Makes Disc Medicine, Inc. (IRON) a Strong Momentum Stock: Buy Now? - Oct 27th, 2025 10:00 am
Does Disc Medicine, Inc. (IRON) Have the Potential to Rally 26.29% as Wall Street Analysts Expect? - Oct 22nd, 2025 7:55 am
Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants - Oct 20th, 2025 10:14 pm